Revenue grew to Rp6.02 trillion for the first half of 2024, but net profit declined to Rp336 billion due to higher operating and impairment expenses. The company maintained strong equity and continued investing in hospital expansion, while managing risks and upholding financial covenants.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.